TITUS ABRAHAM: Open Payments
NPI 1598764540 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,407 in 66 payments from 23 companies in 2025. Trend: 2023 $1,459 · 2024 $2,912 · 2025 $1,407
Food & beverage: $1,407
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $233 |
| Novo Nordisk Inc | 10 | $225 |
| ABBVIE INC. | 9 | $198 |
| Lilly USA, LLC | 7 | $153 |
| Exact Sciences Corporation | 4 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| Astellas Pharma US Inc | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
Products named: MOUNJARO, NURTEC ODT, VRAYLAR, PREVNAR 20, Wegovy, Rybelsus, The Cologuard Plus Collection Kit, Ozempic.
Industry payments across MD — which companies pay providers there.
